Authentag specializes in anti-counterfeit technology. The firm's patented technology enables powerful secure supply chain security through unique item and identity management. Its technology assigns ownership throughout the lifespan of an item. This prevents counterfeits, facilitates absolute recalls, allows network optimization and facilitates new financing options for firms with large inventory holdings. Authentag applies technological expertise from big data analytics and electronic trading. Combining this technology with physical product authentication, Authentag can group, manage, analyze and carry data for large sets of physical items. It can link and lock items through smartphones, proving ownership, tracking fakes or facilitating recalls. The firm's Track.one technology is a blockchain based, distributed ledger solution for compliance with the Drug Supply Chain Security Act of 2013. Authentag has been supporting the medical device field since August 2016 through its BluList SaaS offering. BluList plugs into the FDA to access their 1.5 million GUDID device records. The system then takes over to help manufacturers, distributors, and hospitals track and optimize their inventory usage. Its apps integrate into a powerful web-based admin management tool which manages multiple teams, product expiry, and automated low stock warnings.
